P9. Response to gefitinib in advanced non-small cell lung cancer patients (NSCLC) with rare epidermal growth factor (EGFR) mutations—serbian experience 2011-2014

Davorin Radosavljevic, Dragana Jovanovic, Branislav Perin, Jelena Spasic, Bojan Zaric, Milena Cavic, Radmila Jankovic, Marta Velinovic